Insider Buying: Artiva Biotherapeutics (NASDAQ:ARTV) Director Purchases $135,464.94 in Stock
MarketBeat
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) Director Ra Capital Management, L.P. acquired 15,102 shares of the stock in a transaction on Friday, July 10th. The stock was bought at an average price of $8.97 per share, for a total transaction of $135,464.94. Following the transaction, the director owned 16,811,021 shares in the company, valued at approximately $150,794,858.37. This represents a 0.09% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.
NASDAQ:ARTV